Shetzline Michael 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Jan 22, 2025
Insider Transaction Report
Form 4
Shetzline Michael
SVP, CMO, Head-Res&Drug
Transactions
- Award
Class A Common Stock
2025-01-17+48,224→ 461,943 total
Footnotes (1)
- [F1]Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted March 2, 2022. The earned PSUs were certified and vested on January 17, 2025.